{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:21:22Z","timestamp":1788355282325,"version":"build-2803163510"},"reference-count":38,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"unspecified","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Baotou Municipal Health Commission","award":["2023wsjkkj09"],"award-info":[{"award-number":["2023wsjkkj09"]}]},{"name":"Tianjin Medical University Clinical Special Disease Research Center","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Tianjin Medical University General Hospital Sailing Program","award":["22TSC020"],"award-info":[{"award-number":["22TSC020"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-3-002C"],"award-info":[{"award-number":["TJYXZDXK-3-002C"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82200963"],"award-info":[{"award-number":["82200963"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Tianjin Major Science and Technology Special Projects and Programs","award":["24ZXYXSY00070"],"award-info":[{"award-number":["24ZXYXSY00070"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2026,5,22]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>This study examined how insulin resistance and impaired insulin secretion are associated with hyperglucagonemia during oral glucose tolerance tests (OGTT) in type 2 diabetes mellitus (T2DM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Research design and methods<\/jats:title>\n                    <jats:p>\n                      A retrospective analysis included 247 patients with T2DM treated at Tianjin Medical University General Hospital from October 2022 to March 2025. All underwent a 75\u2009g OGTT, with blood samples collected at 0, 0.5, 1, 2, and 3\u2009hours for glucose, insulin, C-peptide, and glucagon measurement. Insulin resistance was assessed via homeostasis model assessment of insulin resistance (HomaIR) and C-peptide immunoreactivity insulin resistance (CPRIR), while insulin secretion was evaluated using C-peptide area under the curve (AUC\n                      <jats:sub>cp<\/jats:sub>\n                      ), homeostasis model assessment of beta cell function (HomaB), first-phase and second-phase insulin secretion during OGTT (first PH and second PH). Generalized linear models and mediation analyses examined associations between glucagon levels and above indices. Model fitness and robustness were evaluated via residual diagnostics, Cook\u2019s distance, and bootstrapped CIs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Glucagon levels during the OGTT were significantly elevated in patients with severe insulin resistance (HomaIR Q3 and CPRIR Q1), even after adjusting for confounders. In contrast, groups with the poorest insulin secretion (AUC\n                      <jats:sub>cp<\/jats:sub>\n                      Q1, HomaB Q1, first PH Q1, and second PH Q1) did not show elevated glucagon levels compared with those with better secretion. Mediation analysis confirmed that neither AUC\n                      <jats:sub>cp<\/jats:sub>\n                      nor HomaB mediated the relationship between insulin resistance and glucagon levels. Residual diagnostics demonstrated a satisfactory model fit. Furthermore, sensitivity analyses, both by excluding influential points identified via Cook\u2019s distance and by applying bootstrapped CIs, yielded consistent results, thereby affirming the robustness of the model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In T2DM, impaired glucagon suppression during OGTT is associated with insulin resistance closely, highlighting insulin resistance as a key factor in alpha-cell dysfunction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjdrc-2025-005653","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:50:40Z","timestamp":1782823840000},"page":"e005653","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Alpha cell dysfunction in type 2 diabetes: associations with insulin resistance and reduced insulin secretion"],"prefix":"10.1136","volume":"14","author":[{"given":"Lina","family":"Chang","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yian","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Heze Medical College, Heze, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadi","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghua","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2665-4072","authenticated-orcid":false,"given":"Ming","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1408-4098","authenticated-orcid":false,"given":"Qing","family":"He","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"2026090206000992000_14.3.e005653.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2009.02.007"},{"key":"2026090206000992000_14.3.e005653.2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00291074"},{"key":"2026090206000992000_14.3.e005653.3","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.55.04.06.db05-1449"},{"key":"2026090206000992000_14.3.e005653.4","doi-asserted-by":"publisher","DOI":"10.2337\/db11-0251"},{"key":"2026090206000992000_14.3.e005653.5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108188"},{"key":"2026090206000992000_14.3.e005653.6","doi-asserted-by":"publisher","DOI":"10.2337\/diab.21.5.301"},{"key":"2026090206000992000_14.3.e005653.7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20153699","article-title":"Cell Autonomous Dysfunction and Insulin Resistance in Pancreatic \u03b1 Cells","volume":"20","author":"Honzawa","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2026090206000992000_14.3.e005653.8","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1979.237.3.E214"},{"key":"2026090206000992000_14.3.e005653.9","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2840-12-21","article-title":"20\/(fasting C-peptide \u00d7 fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report","volume":"12","author":"Ohkura","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"2026090206000992000_14.3.e005653.10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197663","article-title":"CPR-IR is an insulin resistance index that is minimally affected by hepatic insulin clearance-A preliminary research","volume":"13","author":"Okura","year":"2018","journal-title":"PLoS One"},{"key":"2026090206000992000_14.3.e005653.11","unstructured":"Li X , Zhou ZG , Qi HY , et al . Using Fasting C-Peptide to Replace Insulin in the Modified HOMA Formula for Assessing Insulin Resistance and Pancreatic \u03b2-Cell Function (in Chinese). Journal of Central South University (Medical Sciences) 2004;419\u201323."},{"key":"2026090206000992000_14.3.e005653.12","doi-asserted-by":"crossref","first-page":"110568","DOI":"10.1016\/j.diabres.2023.110568","article-title":"Clinical expert consensus on the assessment and protection of pancreatic islet \u03b2-cell function in type 2 diabetes mellitus","volume":"197","author":"Zhu","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"2026090206000992000_14.3.e005653.13","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.3.295"},{"key":"2026090206000992000_14.3.e005653.14","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00492.2002"},{"key":"2026090206000992000_14.3.e005653.15","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2016-0090"},{"key":"2026090206000992000_14.3.e005653.16","doi-asserted-by":"publisher","DOI":"10.1677\/JOE-08-0290"},{"key":"2026090206000992000_14.3.e005653.17","doi-asserted-by":"crossref","unstructured":"Andersen DB , Holst JJ . Peptides in the regulation of glucagon secretion. Peptides 2022;148. doi:10.1016\/j.peptides.2021.170683","DOI":"10.1016\/j.peptides.2021.170683"},{"key":"2026090206000992000_14.3.e005653.18","doi-asserted-by":"publisher","DOI":"10.1210\/er.2006-0007"},{"key":"2026090206000992000_14.3.e005653.19","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0792"},{"key":"2026090206000992000_14.3.e005653.20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1006639107"},{"key":"2026090206000992000_14.3.e005653.21","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107638"},{"key":"2026090206000992000_14.3.e005653.22","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00315.2010"},{"key":"2026090206000992000_14.3.e005653.23","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-0066"},{"key":"2026090206000992000_14.3.e005653.24","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00344.2014"},{"key":"2026090206000992000_14.3.e005653.25","doi-asserted-by":"publisher","DOI":"10.1126\/science.6126003"},{"key":"2026090206000992000_14.3.e005653.26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/07435800.2011.610855","article-title":"Glucotoxicity and \u03b1 Cell Dysfunction: Involvement of the PI3K\/Akt Pathway in Glucose-Induced Insulin Resistance in Rat Islets and Clonal \u03b1TC1-6 Cells","volume":"37","author":"Shen","year":"2012","journal-title":"Endocr Res"},{"key":"2026090206000992000_14.3.e005653.27","doi-asserted-by":"crossref","DOI":"10.3390\/biom10101404","article-title":"Direct Effects of D-Chiro-Inositol on Insulin Signaling and Glucagon Secretion of Pancreatic Alpha Cells","volume":"10","author":"Filippello","year":"2020","journal-title":"Biomolecules"},{"key":"2026090206000992000_14.3.e005653.28","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00645.2007"},{"key":"2026090206000992000_14.3.e005653.29","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.2.362"},{"key":"2026090206000992000_14.3.e005653.30","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.metabol.2005.03.024","article-title":"Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus","volume":"54","author":"Henkel","year":"2005","journal-title":"Metab Clin Exp"},{"key":"2026090206000992000_14.3.e005653.31","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.4.796"},{"key":"2026090206000992000_14.3.e005653.32","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4275-6"},{"key":"2026090206000992000_14.3.e005653.33","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8227(99)00116-3"},{"key":"2026090206000992000_14.3.e005653.34","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1507\/endocrj.EJ20-0079","article-title":"Plasma glucagon levels measured by sandwich ELISA are correlated with impaired glucose tolerance in type 2 diabetes","volume":"67","author":"Kobayashi","year":"2020","journal-title":"Endocr J"},{"key":"2026090206000992000_14.3.e005653.35","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e01715","article-title":"Positive correlation between fasting plasma glucagon and serum C-peptide in Japanese patients with diabetes","volume":"5","author":"Hosokawa","year":"2019","journal-title":"Heliyon"},{"key":"2026090206000992000_14.3.e005653.36","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1111\/j.1464-5491.2012.03660.x","article-title":"Insulin secretion based on the late oral glucose tolerance test period and incident diabetes: the San Antonio Heart Study","volume":"29","author":"Lorenzo","year":"2012","journal-title":"Diabet Med"},{"key":"2026090206000992000_14.3.e005653.37","doi-asserted-by":"publisher","DOI":"10.1177\/1535370213477974"},{"key":"2026090206000992000_14.3.e005653.38","doi-asserted-by":"publisher","DOI":"10.4161\/isl.1.3.9967"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2025-005653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:00:22Z","timestamp":1788354022000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2025-005653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6,30]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/bmjdrc-2025-005653"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2025-005653","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}